Other people moves come at Boston Scientific and FireFly Metals
Healthcare technology provider Resmed has named Salli Schwartz as its chief investor relations officer. She will report to Mick Farrell, the company’s CEO and chairman of the board.
Schwartz joins from biotech Illumina, where she was head of IR. Prior to that, she served as head of IR and treasurer at market data provider MSCI, where, along with her IR duties, she managed portfolios of cash, short-term investments and high-yield debt.
She has also been global head of IR and communications, among other roles, at Moody’s . . .
Enjoy access to this and more – for free!
Log in or create your free My IR – Essentials account to:
- Get access to 3 free IR deep dives
- More than 100 pieces of insight, plus our exclusive CFO interviews
- Save favorites and get personalized content on your dashboard
- Enjoy 10% off all IR forums
